hydromorphone and celecoxib

hydromorphone has been researched along with celecoxib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K	1
Addante, RA; Charlson, MD; Michelson, JD	1

Reviews

2 review(s) available for hydromorphone and celecoxib

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective. Spine, 2013, May-15, Volume: 38, Issue:11 Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes	2013

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.

Spine, 2013, May-15, Volume: 38, Issue:11

Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes

2013

Other Studies

1 other study(ies) available for hydromorphone and celecoxib

Article	Year
Multimodal analgesia therapy reduces length of hospitalization in patients undergoing fusions of the ankle and hindfoot. Foot & ankle international, 2013, Volume: 34, Issue:11 Topics: Acetaminophen; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anesthesia, General; Anesthesia, Spinal; Ankle Joint; Anti-Inflammatory Agents; Arthrodesis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Pain, Postoperative; Postoperative Care; Prednisone; Pregabalin; Preoperative Care; Pyrazoles; Retrospective Studies; Subtalar Joint; Sulfonamides	2013

Article

Year

Multimodal analgesia therapy reduces length of hospitalization in patients undergoing fusions of the ankle and hindfoot.

Foot & ankle international, 2013, Volume: 34, Issue:11

Topics: Acetaminophen; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anesthesia, General; Anesthesia, Spinal; Ankle Joint; Anti-Inflammatory Agents; Arthrodesis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Pain, Postoperative; Postoperative Care; Prednisone; Pregabalin; Preoperative Care; Pyrazoles; Retrospective Studies; Subtalar Joint; Sulfonamides

2013